Preview

Pharmaceutical Industry in India

Better Essays
Open Document
Open Document
4261 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Pharmaceutical Industry in India
Industry overview
Pharmaceutical sector is an important industry of any modern day economic power. Pharmaceutical industry in India has a very humble past. After independence, development of pharmaceutical industry was one of the top agenda of government along with steel and manufacturing industry. The market was protected against competition for a long period of time by giving incentives to small firms, license-raj etc. Today the Indian pharmaceutical industry is the front-runner science-based industries in the country. Today the industry boasts of wide ranging capabilities in the complex field of drug manufacture and technology. The sector is pegged to be worth US$ 7.3 billion. The annual growth rate is estimated to be around 13%. Reports suggest that the domestic retail market would be worth around US$ 12 billion by 2012. Indian pharmaceutical industry ranks 4th in terms of volume globally and 13th in terms of value. It has 8% share in global sales & 20%-24% share in production of generic drugs. The domestic players satisfy almost all of the country’s demand for formulations and bulk drugs.
Indian firms aren’t limited to domestic market; they are now competing head on with multi national players in international arena. For many firms, exports constitute 60%-70% of the total revenue earned. Reasons for this strong growth are low cost of manufacturing, low cost of R&D, innovative scientific manpower etc. The total pharmaceutical exports in 2007-08 clocked US$ 6.68 billion against US$ 5.73 billion in 2006-07 recording a growth rate of 16 per cent.

India is poised to be one of the fastest growing pharmaceutical markets in the world. This has led to entry of many major companies in the Indian market and a huge amount of FDI inflow. Evolution of the Indian Pharmaceutical Industry
The Indian regulatory system made several arrangements to protect the domestic pharmaceutical industry from foreign competition in its nascent phase. One of them was



References: http://www.pharmaceutical-drug-manufacturers.com/pharmaceutical-industry/ http://www.thehindubusinessline.com/iw/2004/07/25/stories/2004072500401000.htm http://www.ibef.org/industry/pharmaceuticals.aspx www.indiainbusiness.nic.in/industry-infrastructure/industrial-sectors/drug-pharma.htm

You May Also Find These Documents Helpful

  • Good Essays

    The Pharmaceutical industry has several high entry barriers as shown in figure 1. Economies of scale, product differentiation, government policy and capital requirements and financial services are few barriers for new entrant. Level of threat from rivalry is also high in this industry. Industry has presence of large number of small firms of a similar size. They are in direct competition with one another,…

    • 1056 Words
    • 5 Pages
    Good Essays
  • Powerful Essays

    Ego Executive Report

    • 3226 Words
    • 13 Pages

    Grace, C. (2004), The Effect of Changing Intellectual Property on Pharmaceutical Industry Prospects in India and China: Consideration for Access to Medicines, DFID Health Systems Resource Centre, June.…

    • 3226 Words
    • 13 Pages
    Powerful Essays
  • Powerful Essays

    William, G. (2007). The Emergence of India’s Pharmaceutical Industry and Implications for the US Generic…

    • 4700 Words
    • 19 Pages
    Powerful Essays
  • Good Essays

    Retail Pharmacies

    • 4248 Words
    • 17 Pages

    The pharmacy trade in the country generates an estimated business of Rs. 32,000 crore, apart from about Rs. 18,000 added by hospital pharmacies and exports. Almost all the chemists beside selling allopathic medicines also offer OTC and alternate medicines, surgicals, rehabilitation aids and bodycare products like soaps, tooth pastes, hair oils, shampoos, cleansing lotions and neutraceuticals, among others, for sale which according to rough estimates generate an additional turnover of about Rs. 15,000 crore.…

    • 4248 Words
    • 17 Pages
    Good Essays
  • Good Essays

    There are number of factors that have contributed towards this phenomenal growth in the drug industry. The initial event that initiated the growth was India’s agreement with WTO which gave protection to intellectual property rights and assurance to international investors. Also, there are several internal factors within India which have successfully contributed to the growth of the industry. Similar to China, India has comparative advantage in manufacturing and packaging which encouraged Western companies to outsource in India. The comparative advantage has been gained due to abundance of educated work force, low wage rates and the wide spread use of English as a business language. This latter factor, the wide use of English language is one of the main reasons why Western companies chose India over China. For foreign investors, it is much easier to conduct business…

    • 860 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    There were two pharmaceutical companies that were looking for ways to expand globally to position themselves in a competitive advantage from their competitors. One was located in the United States, which was Eli Lilly and Company and the other one was located in India, which was Ranbaxy Laboratories. Research and development was crucial to Lilly’s long-term success. Ranbaxy Laboratories was a firm that was evolved into a serious research-oriented firm. With the change, in the government, India was attracting foreign investors in the pharmaceutical industry. Lilly decided to form the joint venture in India to focus on marketing Lilly’s drugs there, and a formal JV agreement was signed in November 1992.…

    • 3230 Words
    • 13 Pages
    Powerful Essays
  • Best Essays

    For the purposes of this report, we will perform a detailed overview of the pharmaceutical industry, including defining the industry and its strategic forces, an environmental analysis, the forces of competition within the industry and value chain analysis as well the role of IS/IT in the industry. Four companies will be individually researched within that industry and this individual analysis will include financial information as well as industry market sources. A clear plan will also be outlined for further analysis on these companies.…

    • 3312 Words
    • 14 Pages
    Best Essays
  • Better Essays

    Leading Pharmaceutical companies have, in recent times, been alarmed by the some adverse regulatory rulings in India. First in a landmark decision in March 2012, the Indian Patent Office allowed a domestic company (Natco Pharma Ltd.) to sell a generic version of Bayer AG's cancer drug ‘Nexavar’ on the grounds that the German company’s drug not affordable to the local populace due to cost reasons. Then in March 2013, the Honorable Supreme Court of India denied patent protection to Novartis’s blockbuster cancer drug ‘Gleevac’ stating that Novartis had resorted to ‘evergreening’ in an effort to extend their monopoly beyond the standard patent period. The Indian ruling has attracted global attention especially from the Big Pharma companies here in the U.S. The view is that India has scant disregard of intellectual property (IP) and pharmaceutical patent polices and the rulings are geared to favor local generic drug makers by way of issuing compulsory licenses. Pfizer’s Chief IP counsel Roy F. Waldron had, in written testimony before the US House Committee hearing on US-India trade relations in March 2013, accused India of being anti-IP rights. In his testimony he mentions that the “Business environment (in India) for innovative industries has deteriorated significantly in recent history” and “India has taken steps that call into question the sustainability of foreign investment and the ability of American companies to compete fairly.”…

    • 1572 Words
    • 7 Pages
    Better Essays
  • Satisfactory Essays

    Costlier manufacturing practices due to strict governmental control, soaring prices in 1990s, invasion of cheap generics to the USA market as opposed to low costs in India and new regulations that opened Indian market to foreign investments (up to 51%) created tempting conditions to enter one of the emerging huge markets of the world.…

    • 914 Words
    • 4 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Eli Lily Case Study

    • 489 Words
    • 2 Pages

    It was a right strategy for Eli Lilly that started a joint venture with Ranbaxy to enter the Indian market. First of all, Ranbaxy was the second largest pharmaceutical company that manufactures bulk drugs and generic drugs in India, with a domestic market share of 15 per cent. It had established broad distribution network, and it was the second largest exporter of all products in India. Ranbaxy’s capital costs were 50 per cent to 75 per cent lower than those of comparable U.S. plants. Second, the timing was perfect for Eli Lilly to enter the Indian market. During 1970s, the Patents Act 1970 and the Drug Price Control Order (DPCO) was issued. And India was opening its drug market. Third, there was possibility to conduct cheap clinical trials in India.…

    • 489 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    Timmons, H. (2010). India Expands Role as Drug Producer. The New York Times. Retrieved from http://www.nytimes.com/2010/07/07/business/global/07indiadrug.html?pagewanted=all&_r=0…

    • 1526 Words
    • 5 Pages
    Powerful Essays
  • Powerful Essays

    Pharmaceutical is the core of Bangladesh’s Healthcare sector, and serves as one of the most important manufacturing industry. With a history since 1950s, the industry has now turned one of the most successful pharmaceuticals manufacturing industry among the developing countries. Presently, the industry meets 97% of local demand and exports to more than 80 countries.…

    • 1573 Words
    • 7 Pages
    Powerful Essays
  • Good Essays

    Pharmacy Sop

    • 1074 Words
    • 5 Pages

    The last decade has been an absolutely exciting time in the journey of the Indian Pharmaceutical Industry. With the signing of the General Agreement of Trade and Tariff and the World Trade Organization Treaty, India agreed to recognize both product and process patents. This made patented drugs with a modified process. Due to this, India has developed tremendous competitive edge in the manufacturing bulk drugs and formulations. These abundant opportunities with their challenges are where I see myself making a contribution to the Indian Pharmaceutical Industry and in turn the world at large. How and why require just brief journey into my past.…

    • 1074 Words
    • 5 Pages
    Good Essays
  • Better Essays

    iii. Abhinav Agrawal, Kamal Dua, Vaibhav Garg, U.V.S. Sara and Akash Taneja, 27- Challenges and Opportunities for The Indian Pharma Industry, Health Administrator vol. xx number 1&2 : 109-113…

    • 5423 Words
    • 22 Pages
    Better Essays
  • Powerful Essays

    The Indian Pharmaceutical industry has been witnessing phenomenal growth in recent years, driven by rising consumption levels in the country and strong demand from export markets. The pharmaceutical industry in India is estimated to be worth about US$ 8 bn, growing at an annual rate of 12-15%. In world rankings, the domestic industry stands 3rd in terms of volume and 12th in value growth terms. The ranking in value terms may also be a reflection of the low prices at which medicines are sold in the country.…

    • 1950 Words
    • 8 Pages
    Powerful Essays